Supported by educational grants from Janssen Biotech and AbbVie Pharmaceuticals
Produced by Haymarket Medical Education
Inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, is a chronic, often debilitating, lifelong condition. Primary care providers need to know how to distinguish IBD from other gastrointestinal disorders (GI) and when to refer patients to GI specialists for a more detailed workup and treatment. Ideally, care of the patient with IBD should be co-managed by a GI and a primary care provider. This educational program is designed to help primary care providers recognize the manifestations of IBD and make timely referrals to specialists while continuing to oversee the patient’s general health. It is also designed to acquaint clinicians with the spectrum of available treatments for Crohn’s disease and ulcerative colitis, including newer biologic agents.
The activity is designed for primary care clinicians—especially nurse practitioners (NPs) and physician assistants (PAs) working in primary care (family medicine and internal medicine).
At the conclusion of this activity, participants should be better able to:
Recognize the manifestations of inflammatory bowel disease (IBD) and make the diagnosis on a timely basis, differentiating it from irritable bowel syndrome and other gastrointestinal disorders commonly seen in primary care practice
Make timely referrals of IBD patients to specialist care while continuing to oversee the general health of the patient, using an approach based on shared decision-making and multidisciplinary collaboration
Describe the benefits and side effects of newer IBD therapies, including biologics, and their role in a comprehensive treatment plan
Conflict Of Interest Disclosure Policy
In accordance with the ACCME Standards for Commercial Support, the Albert Einstein College of Medicine and Haymarket Medical Education (HME) require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. HME and Global Education resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational activities.
CME Reviewer Victor B. Hatcher, PhD Associate Dean CME Albert Einstein College of Medicine Bronx, NY
Victor B. Hatcher, PhD, has no relevant financial relationships to disclose.
Course Director Lawrence J. Brandt, MD Professor, Department of Medicine (Gastroenterology) Professor, Department of Surgery Montefiore Medical Center Bronx, NY
Lawrence J. Brandt, MD, has no relevant financial relationships to disclose.
Michele Kissous-Hunt, PA-C, DFAAPA Gastroenterology Physician Assistant, Practice of Arthur Asher Kornbluth, MD, PC Chair of the Nurse and Advanced Practice Provider, Crohn’s & Colitis Foundation National Scientific Advisory Committee Adjunct Faculty, Physician Assistant Program, Touro College of Health Sciences New York, NY
Michele Kissous-Hunt, PA-C, DFAAPA, serves on the speakers’ bureau for AbbVie Pharmaceuticals and Janssen Biotech.
Accredited Provider Disclosure
The staff of the Center for Continuing Medical Education of Albert Einstein College of Medicine has nothing to disclose with regard to commercial support.
Publishing Staff Disclosures
Susan Basilico, Jeff Forster, and Angie Ladas of Haymarket Medical Education have nothing to disclose with regard to commercial support.
AMA PRA Category 1 Credit(s)TM
Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Albert Einstein College of Medicine designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 CreditTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Unlabeled Use
This CME activity will not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient's medical condition.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Janssen Biotech, AbbVie Pharmaceuticals, Albert Einstein College of Medicine, and Haymarket Medical Education. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/Exam History, which you can access at any time.